BMRN compared with BNTX: revenue, margins and what each company keeps, and the suppliers and customers both name

BMRNBioMarin Pharmaceutical Inc

Mkt capRevenueRevenue

BNTXBioNTech SE

Mkt capRevenueRevenue

Compare

BMRNBioMarin Pharmaceutical Inc

BNTXBioNTech SE

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BMRN1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.2%▲+3.82%×0.46

BNTX

No earnings history for BNTX.

= impliedBMRN realized, solidBNTX realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

BMRNBioMarin Pharmaceutical Inc

57.43· pre 56.01· delayed

Mkt cap$11.3BRevenue$990MQ2 FY26Revenue$3.2BFY25

BNTXBioNTech SE

87.49· pre 87.49· delayed

Pre-marketNov 3 '26delayed

Mkt cap$22.0MRevenue—Revenue—

Compare

Pre-marketNov 3 '26delayed

BMRNBioMarin Pharmaceutical Inc

BNTXBioNTech SE

57.43pre 56.01delayed

Price

87.49pre 87.49delayed

$11.3B

Mkt cap

$22.0M

Q2 FY26$990M

Revenue

—

FY25$3.2B

Revenue

—

BMRN57.43vsBNTX87.49Pre-marketNov 3 '26delayed